Showing results (221-230 of 324) with videos related to

Sort By:
Pageof 33
The American Surgeon|May 11, 2022
Laparoscopic Heller Myotomy With EGD and Balloon Dilation: A Durable Solution for AchalasiaBenjamin R Zambetti, William G Murphy, Domenic Craner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative GroupG Bonadonna, M Zambetti, C Bumma, et al.
American Journal of Surgery|April 5, 2022
In for a Penny, in for a Pound: Obesity weighs heavily on both cost and outcome in traumaWilliam P Zickler, John P Sharpe, Richard H Lewis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 17, 2011
Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) studyV Semiglazov, W Eiermann, M Zambetti, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2018
Safety profile of subcutaneous trastuzumab for the treatment of patients with HER2-positive early or locally advanced breast cancer: primary analysis of the SCHEARLY studyMilvia Zambetti, Filippo Montemurro, Paolo Morandi, et al.
Acta Neuropathologica|February 12, 2018
Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneousEmilia M Pinto, Dima Hamideh, Armita Bahrami, et al.
Journal of Biological Regulators and Homeostatic Agents|April 7, 2016
Ancillary therapy of intranasal T-LysYal® for patients with allergic, non-allergic, and mixed rhinitisM Gelardi, S Taliente, M L Fiorella, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2011
Developmental arrest of T cells in Rpl22-deficient mice is dependent upon multiple p53 effectorsJason E Stadanlick, Zhiqiang Zhang, Sang-Yun Lee, et al.
Genes & Development|August 26, 1998
Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignanciesG Packham, E L White, C M Eischen, et al.
Pageof 33